Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-155000
Filing Date
2025-07-02
Accepted
2025-07-02 16:44:07
Documents
4
Period of Report
2025-08-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A d87905dpre14a.htm PRE 14A 181715
2 GRAPHIC g87905g01k14.jpg GRAPHIC 183667
3 GRAPHIC g87905g13k14.jpg GRAPHIC 191208
4 GRAPHIC g87905g19x24.jpg GRAPHIC 69409
  Complete submission text file 0001193125-25-155000.txt   794975
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41536 | Film No.: 251101975
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)